Cell Impact AB (CI) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.104x

Based on the latest financial reports, Cell Impact AB (CI) has a cash flow conversion efficiency ratio of -0.104x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-19.56 Million ≈ $-2.10 Million USD) by net assets (Skr187.48 Million ≈ $20.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CI equity to assets ratio to measure how much of total assets are equity-financed.

Cell Impact AB - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Cell Impact AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow reinvestment rate of Cell Impact AB to assess the company's total reinvestment commitment from operating cash flow.

Cell Impact AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Cell Impact AB ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Altiplano Metals Inc
V:APN
3.221x
Moleculin Biotech Inc
NASDAQ:MBRX
-0.358x
Yowie Group Ltd
AU:YOW
-0.091x
Clear Blue Technologies International Inc
V:CBLU
0.126x
VR Resources Ltd
V:VRR
-0.026x
Borqs Technologies Inc.
NASDAQ:BRQSF
N/A
The Income & Growth VCT
LSE:IGV
-0.017x
Bathurst Metals Corp
V:BMV
-0.113x

Annual Cash Flow Conversion Efficiency for Cell Impact AB (2012–2024)

The table below shows the annual cash flow conversion efficiency of Cell Impact AB from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Cell Impact AB market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 Skr219.08 Million
≈ $23.58 Million
Skr-62.23 Million
≈ $-6.70 Million
-0.284x +14.65%
2023-12-31 Skr303.37 Million
≈ $32.65 Million
Skr-100.97 Million
≈ $-10.87 Million
-0.333x -1.91%
2022-12-31 Skr324.35 Million
≈ $34.90 Million
Skr-105.93 Million
≈ $-11.40 Million
-0.327x +45.88%
2021-12-31 Skr142.62 Million
≈ $15.35 Million
Skr-86.08 Million
≈ $-9.26 Million
-0.604x -156.00%
2020-12-31 Skr201.89 Million
≈ $21.73 Million
Skr-47.59 Million
≈ $-5.12 Million
-0.236x +74.10%
2019-12-31 Skr45.05 Million
≈ $4.85 Million
Skr-41.01 Million
≈ $-4.41 Million
-0.910x +59.09%
2018-12-31 Skr19.14 Million
≈ $2.06 Million
Skr-42.57 Million
≈ $-4.58 Million
-2.225x -224.24%
2017-12-31 Skr23.09 Million
≈ $2.48 Million
Skr-15.84 Million
≈ $-1.70 Million
-0.686x -218.20%
2016-12-31 Skr41.38 Million
≈ $4.45 Million
Skr-8.92 Million
≈ $-960.18K
-0.216x +90.92%
2015-12-31 Skr2.34 Million
≈ $251.78K
Skr-5.56 Million
≈ $-598.14K
-2.376x -233.57%
2014-12-31 Skr8.22 Million
≈ $884.78K
Skr-5.86 Million
≈ $-630.13K
-0.712x -45.82%
2013-12-31 Skr16.08 Million
≈ $1.73 Million
Skr-7.86 Million
≈ $-845.36K
-0.488x +89.46%
2012-12-31 Skr1.68 Million
≈ $181.13K
Skr-7.80 Million
≈ $-839.57K
-4.635x --

About Cell Impact AB

ST:CI Sweden Metal Fabrication
Market Cap
$2.26 Million
Skr21.00 Million SEK
Market Cap Rank
#29845 Global
#683 in Sweden
Share Price
Skr0.07
Change (1 day)
+2.30%
52-Week Range
Skr0.02 - Skr0.59
All Time High
Skr64.00
About

Cell Impact AB (publ) manufactures and sells bipolar flow plates for hydrogen fuel cells and electrolyzers in the United States, Sweden, Other Europe, and Asia. The company offers production series of flow plates; design for manufacturing and other design services; tools and prototypes; local production; and leak testing, cleaning options, and advanced measurement instruments. The company was inc… Read more